MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

Protect from moisure.

Provenance

This compatibility recommendation is derived from Zamadol SR 50mg capsules (Viatris UK Healthcare Ltd).

Stability Notes

Protect from moisure.

Provenance

This compatibility recommendation is derived from Zamadol SR 50mg capsules (Viatris UK Healthcare Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Zanidip 10mg tablets (Recordati Pharmaceuticals Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Zanidip 10mg tablets (Recordati Pharmaceuticals Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Zanidip 20mg tablets (Recordati Pharmaceuticals Ltd).

Stability Notes

Protect from light.

Provenance

This compatibility recommendation is derived from Zanidip 20mg tablets (Recordati Pharmaceuticals Ltd).

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from Solpadol 30mg/500mg capsules (Sanofi), Tylex 30mg/500mg capsules (UCB Pharma Ltd) and generic co-codamol 30mg/500mg capsules.

Stability Notes

Store in airtight containers. Protect from light.

Provenance

This compatibility recommendation is derived from generic co-codamol 30mg/500mg tablets.

Stability Notes

Protect from light. Sensitive to oxygen.

Provenance

This compatibility recommendation is derived from Zaponex 100mg tablets (Leyden Delta B.V.) and Denzapine 100mg tablets (Britannia Pharmaceuticals Ltd).

Stability Notes

Protect from light. Sensitive to oxygen.

Provenance

This compatibility recommendation is derived from Zaponex 25mg tablets (Leyden Delta B.V.) and Denzapine 25mg tablets (Britannia Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.